+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Effect of chronic administration of naltrexone on brain mu- and kappa-opioid receptors and responses to U-50,488H, a kappa-opioid receptor agonist in the mouse



Effect of chronic administration of naltrexone on brain mu- and kappa-opioid receptors and responses to U-50,488H, a kappa-opioid receptor agonist in the mouse



FASEB Journal 9(3): A102




(PDF emailed within 1 workday: $29.90)

Accession: 031070034

Download citation: RISBibTeXText



Related references

Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat. European Journal of Pharmacology 235(1): 23-30, 1993

Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat. Pharmacology 39(3): 145-153, 1989

Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat. Pharmacology 51(5): 323-330, 1995

Effect of acute and chronic administration of dizocilpine on the analgesic action of U-50,488H and brain and spinal cord kappa-opioid receptors. FASEB Journal 9(3): A102, 1995

Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse. Brain Research 649(1-2): 111-116, 1994

The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats. Journal of Pharmacology and Experimental Therapeutics 264(2): 631-637, 1993

Chronic cocaine injections attenuate behavioral response of kappa-opioid receptors to U-50,488H agonist. Bulletin of Experimental Biology and Medicine 140(3): 320-322, 2005

Renal responses produced by microinjection of the kappa opioid receptor agonist, U50-488H, into sites within the rat lamina terminalis. Pharmacology Research and Perspectives 3(2): E00117, 2015

Effect of multiple injections of U-50,488H, a kappa-opioid receptor agonist, on the activity of nitric oxide synthase in brain region and spinal cord of mice. General Pharmacology 29(3): 397-399, 1997

Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. European Journal of Pharmacology 321(3): 265-271, 1997

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. Embo Journal 17(4): 886-897, 1998

Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist. Brain Research 749(2): 347-350, 1997

Effects of rat brain kappa 1- and kappa 2-opioid receptors after chronic treatment with non-peptide kappa-agonists. Journal of Pharmacy and Pharmacology 50(10): 1121-1125, 1998

Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors. Proceedings of the National Academy of Sciences of the United States of America 85(11): 4061-4065, 1988

Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs. Neuropharmacology 32(8): 751-760, 1993